Skip to content
The Nexus
HEALTHJun 16 · 13:32 UTCSTAT NEWSEd Silverman

STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more

Medicare will cover weight loss drugs for adults 65 and older starting next month via a temporary government program. Novo Nordisk plans to seek Chinese regulatory approval for its Wegovy weight loss pill soon amid competition from generic drugmakers.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
MedicareorganizationTrump administrationorganizationMike DoustdarpersonNovo NordiskorganizationWegovyproductOzempicproductsemaglutidetopicBALANCE programtopicBridge programtopicChinaplace
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting